Icon (ICLR) Other Non Operating Income (2020 - 2026)
Icon's (ICLR) quarterly Other Non Operating Income came in at $670000.0 in Q2 2026, down 97.21% year-over-year from $24.0 million in Q2 2025, and up 109.77% quarter-over-quarter from -$6.9 million in Q3 2025.
Analysis
Icon (ICLR) Other Non Operating Income (2020 - 2026) Analysis & Trends
Icon (ICLR) has reported Other Non Operating Income for 7 consecutive years, with $670000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non Operating Income fell 97.21% year-over-year to $670000.0 in Q2 2026; TTM through Jun 2026 was $35.9 million, a 14.04% increase from a year earlier, with the FY2024 full-year figure at -$18.1 million, down 240.02% from the prior year.
- Other Non Operating Income was $670000.0 for Q2 2026 at Icon, up from -$6.9 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $35.4 million in Q4 2022 and troughed at -$36.9 million in Q3 2022.
- A 5-year average of $254812.5 and a median of $786500.0 in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income slumped 1038.23% in 2022 and surged 619.01% in 2025, its largest moves.
- Over 5 years, Other Non Operating Income stood at $35.4 million in 2022, then sank by 56.55% to $15.4 million in 2023, then plunged by 295.34% to -$30.0 million in 2024, then soared by 77.17% to -$6.9 million in 2025, then soared by 109.77% to $670000.0 in 2026.
- The last three Other Non Operating Income figures came in at $670000.0 (Q2 2026), -$6.9 million (Q3 2025), and $24.0 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 670,000.00 |
| Sep 30, 2025 | -6.86 Mn |
| Jun 30, 2025 | 24.02 Mn |
| Mar 31, 2025 | 18.10 Mn |
| Dec 31, 2024 | -30.05 Mn |
| Sep 30, 2024 | 19.43 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Mar 31, 2024 | -10.81 Mn |
| Dec 31, 2023 | 15.38 Mn |
| Sep 30, 2023 | -4.71 Mn |
| Jun 30, 2023 | 903,000.00 |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 35.40 Mn |
| Sep 30, 2022 | -36.93 Mn |
| Jun 30, 2022 | -17.82 Mn |
| Mar 31, 2022 | -7.32 Mn |
| Dec 31, 2021 | -7.97 Mn |
| Sep 30, 2021 | -7.19 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | -1.06 Mn |